It’s what’s missing in the tumor genome, not what’s mutated, that thwarts treatment of metastatic melanoma with immune checkpoint blockade drugs, researchers at The University of Texas MD Anderson Cancer Center report in Science Translational Medicine.
Anyone who uses an employee badge to enter a building may understand how a protein called ENL opens new possibilities for treating acute myeloid leukemia (AML), a fast-growing cancer of bone marrow and blood cells and the second most common type of leukemia in children and adults.
Adding two blood-borne proteins associated with cancer cell migration increases the predictive ability of the current biomarker for pancreatic cancer to detect early stage disease, a research team from The University of Texas MD Anderson Cancer Center reports in the Journal of the National Cancer Institute.
Discovery of a dual role played by the enzyme phosphoglycerate kinase 1 (PGK1) may indicate a new therapeutic target for glioblastoma, an often fatal form of brain cancer, according to researchers at The University of Texas MD Anderson Cancer Center.
The 2017 Thomas Willis Award for significant translational contributions to clinical stroke research from the American Heart Association has been awarded to Jaroslaw Aronowski, Ph.D., professor, vice-chair and the Roy M. and Phyllis Gough Huffington Chair in Neurology at McGovern Medical School at The University of Texas Health Science Center at Houston (UTHealth).
Barbara J. Stoll, M.D., dean of McGovern Medical School at The University of Texas Health Science Center at Houston (UTHealth), has been awarded the 2017 Women Leaders in Medicine award by the American Medical Student Association (AMSA).
Melanoma patients’ response to a major form of immunotherapy is associated with the diversity and makeup of trillions of potential allies and enemies found in the digestive tract, researchers at The University of Texas MD Anderson Cancer Center report at the ASCO-Society for Immunotherapy in Cancer meeting in Orlando.
For women with a rare subtype of epithelial ovarian or peritoneum cancer, known as low-grade serous carcinoma (LGSC), hormone maintenance therapy (HMT) may significantly improve survival, according to a new study from researchers at The University of Texas MD Anderson Cancer Center.
Jaromir Bobek of Harris Health System's Ben Taub Hospital prides himself on his cardiology team's preparation and attention to detail. The service line routinely receives national recognition for its expertise and quick treatment of some of the most severe heart attack cases.
Women with early-stage breast cancer who had an intermediate risk recurrence score (RS) from a 21-gene expression assay had similar outcomes, regardless of whether they received chemotherapy, a new study from The University of Texas MD Anderson Cancer finds.
The emergence of e-cigarettes as a nicotine product has left scientists with many questions about their impact on health, including how the product interacts with depression. A new study by researchers at The University of Texas Health Science Center at Houston (UTHealth), published today in Nicotine & Tobacco Research, found a connection between depression and initiation of e-cigarette use among college students.
Recognizing a critical need to address disparities in cancer care, The University of Texas MD Anderson Cancer Center has been designated as an ECHO superhub for oncology by the ECHO Institute at the University of New Mexico Health Science Center (UNMHSC). MD Anderson is one of just nine ECHO superhub sites in the world and the first focused on oncology.
A team from The University of Texas MD Anderson Cancer Center describes this week in the journal Nature a series of preclinical experiments using patient-derived tumor xenografts (PDXs) and mouse models that point to potential treatments for patients with a rapidly-progressing and resistant subgroup of tumor cells.
As part of a landmark patient safety study, Eric Thomas, M.D., M.P.H., professor of medicine at McGovern Medical School at The University of Texas Health Science Center at Houston (UTHealth), has been appointed to the Board of Advisors of the National Patient Safety Foundation (NPSF).
Lillian Kao, M.D., M.S., professor of surgery at The University of Texas Health Science Center at Houston (UTHealth), has been appointed chief of the Division of Acute Care Surgery at McGovern Medical School at UTHealth.
A new stent opens up iliac arteries, the three arteries that run from the end of the aorta down to the pelvis and legs. When these arteries are clogged it can cause a whole host of problems.
Breast cancer patients with dense breast tissue have almost a two-fold increased risk of developing disease in the contralateral breast, according to new research from The University of Texas MD Anderson Cancer.
The University of Texas MD Anderson Cancer Center returns to Southern California this month with its Making Cancer History® Seminar, 3:30-5:30 p.m. Feb. 20 at the Renaissance Indian Wells Resort and Spa, 44400 Indian Wells Lane.
A new method has been found for identifying therapeutic targets in cancers lacking specific key tumor suppressor genes. The process, which located a genetic site for the most common form of prostate cancer, has potential for developing precision therapy for other cancers, such as breast, brain and colorectal, say researchers at The University of Texas MD Anderson Cancer Center. Study results were published in the Feb. 6 online issue of Nature.
Two faculty members from The University of Texas Health Science Center at Houston (UTHealth) have been elected to The University of Texas Kenneth I. Shine., M.D., Academy of Health Science Education.
In honor of World Cancer Day on Feb. 4, The University of Texas MD Anderson Cancer Center calls for health care providers, organizations, governments and individuals to unite in the common goal of eliminating cancer. Driven to accelerate progress toward Making Cancer History®, MD Anderson is proud to support this global effort.
A pacemaker the size of a nickel can now be implanted in patients.
Beginning in the mid-1980s, an epidemic of severe invasive infections caused by Streptococcus pyogenes (S. pyogenes), also known as group A streptococcus (GAS), occurred in the United States, Europe, and elsewhere. The public became more aware of these sometimes fatal infections, commonly known as the “flesh-eating disease.” A new study in The American Journal of Pathology reports that the bacteria’s full virulence is dependent on the presence of two specific cytotoxins.
Oscar Betancourt knows letting his diabetes get out of control is serious. So when a sore on his foot was not healing, he knew it required immediate attention. Fortunately, his medical team knew to refer him to in-house experts who specialize in saving diabetes-ravaged limbs from amputation.
Two new clinical trials for pediatric brain cancer have begun at The University of Texas Health Science Center at Houston (UTHealth) and Children’s Memorial Hermann Hospital.
The University of Texas MD Anderson Cancer Center and Guardant Health today announced a multi-year partnership designed to accelerate comprehensive liquid biopsy technology into the standard of care in cancer treatment.
Charles Aubrey “Mickey” LeMaistre, M.D., past president of The University of Texas MD Anderson Cancer Center and a pioneering crusader against the harmful effects of tobacco use and catalyst of the field of cancer prevention, died today in Houston. He was 92. LeMaistre came to MD Anderson as president in 1978 after serving seven years as chancellor of The University of Texas System.
Seventy-eight percent of employees at Houston hospitals are overweight or obese, according to a study by researchers at The University of Texas Health Science Center at Houston (UTHealth) School of Public Health.
A volume decrease in specific parts of the brain’s hippocampus – long identified as a hub of mood and memory processing – was linked to bipolar disorder in a study led by researchers at The University of Texas Health Science Center at Houston (UTHealth). The research was published today in Molecular Psychiatry, part of the Nature Publishing Group.
Physical therapist Jorge Neira is helping Ruben Arellano regain use of his arms and the ability to walk. Arellano had a baseball-sized tumor removed from his head. The two share successes and setbacks on the arduous road to recovery at Harris Health System's CARF-accredited hospital.
Cancer cells often delete genes that normally suppress tumor formation. These deletions also may extend to neighboring genes, an event known as “collateral lethality,” which may create new options for development of therapies for several cancers.
Catherine Graves, a registered occupational therapist at Harris Health System, received the Horizon Award from the Texas Occupational Therapy Association. The award is given to a practitioner with less than five years of experience and who has made great contributions to the profession.
The impact of the chemicals in the plastic products used in pediatric intensive care units will be the focus of a new $1 million study led by Andrea Duncan, M.D., M.S.ClinRes, associate professor at McGovern Medical School at The University of Texas Health Science Center at Houston (UTHealth) and an attending physician with Children’s Memorial Hermann Hospital.
– Imagine a day when you visit the doctor’s office for your annual physical. Your physician orders routine tests – cholesterol, glucose and blood count – but they also order a sequence of your genome, all 3 billion letters of it. Routine genomic testing is not far away, according to researchers at The University of Texas Health Science Center at Houston (UTHealth).
Vescor LLC, a new company focused on discovery and development of autophagy targeted therapeutics for cancer treatment, has been formed by The University of Texas MD Anderson Cancer Center, Deerfield Management and two leading autophagy experts.
As national vaccination rates for the human papillomavirus (HPV) remain low, The University of Texas MD Anderson Cancer Center has again united with the 68 other National Cancer Institute (NCI)-designated cancer centers in issuing a joint statement endorsing the recently revised vaccination recommendations from the Centers for Disease Control and Prevention (CDC).
Despite the mandatory addition of folic acid to enriched grain products in the United States, many women still do not consume adequate amounts of this important vitamin, according to an editorial written by Laura E. Mitchell, Ph.D., professor in the Department of Epidemiology, Human Genetics and Environmental Sciences at The University of Texas Health Science Center at Houston (UTHealth) School of Public Health.
Researchers are looking at a drug once used to improve blood flow in damaged hearts in thousands of patients as a possible treatment option for triple negative breast cancer (TNBC).
A new genetic-based model may explain how a common form of early-stage breast cancer known as ductal carcinoma in situ (DCIS) progresses to a more invasive form of cancer say researchers at The University of Texas MD Anderson Cancer Center.
The University of Texas MD Anderson Cancer Center and Affimed N.V., a clinical stage biopharmaceutical company focused on discovering and developing highly targeted cancer immunotherapies, today announced an exclusive strategic clinical development and commercialization collaboration to evaluate Affimed’s TandAb technology in combination with MD Anderson’s natural killer cell (NK) product.
Positive results of an investigational medication study for primary progressive multiple sclerosis were published online in today’s New England Journal of Medicine in a paper led by senior author Jerry Wolinsky, M.D., of McGovern Medical School at The University of Texas Health Science Center at Houston (UTHealth).
The detection of prions in the blood of patients with variant Creutzfeldt-Jakob disease could lead to a noninvasive diagnosis prior to symptoms and a way to identify prion contamination of the donated blood supply, according to researchers at McGovern Medical School at The University of Texas Health Science Center at Houston (UTHealth).
Women often neglect their own heart health during the holidays and can suffer serious health problems.
A genetic discovery by a team led by Dianna Milewicz, M.D., Ph.D., of The University of Texas Health Science Center at Houston (UTHealth) could help explain a cause of a mysterious artery-damaging disease that may affect up to an estimated 5 million Americans and often strikes without warning.
In the first study evaluating patient-reported cosmetic outcomes in a population-based cohort of older women with breast cancer, The University of Texas MD Anderson Cancer Center researchers found that less radiation was associated with improved cosmetic satisfaction long-term.
In a pilot study conducted at The University of Texas MD Anderson Cancer Center, image-guided biopsies identified select breast cancer patients who achieved pathologic complete response (pCR) after chemotherapy and/or targeted therapy, neoadjuvant systemic therapy (NST).
Researchers from the Michael & Susan Dell Center for Healthy Living at The University of Texas Health Science Center at Houston (UTHealth) School of Public Health were the senior scientific editors for the first-ever U.S. Surgeon General’s Report on E-Cigarette Use Among Youth and Young Adults, released today.
In recognition of their efforts to develop new treatments for fungal infections and stress-related chronic illnesses, respectively, Michael Lorenz, Ph.D., and Xiaodong Cheng, Ph.D., of The University of Texas Health Science Center at Houston (UTHealth) have been elected fellows by the American Association for the Advancement of Science (AAAS).
RSS
Medicine keyboard_arrow_right
Sciencekeyboard_arrow_right
Life keyboard_arrow_right
Business keyboard_arrow_right
Journal News keyboard_arrow_right
By Location keyboard_arrow_right
Meetings, Grants, and Events keyboard_arrow_right